Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Monmouth Junction, USA
7 Deer Park Drive
Suite H
Monmouth Junction, NJ, 08852
USA

People

CEO
President and COO

Funding

TOTAL $5.6M
FUNDING TOTAL $5.6M
Partial Close, 7/2011
$4M
Grant, 11/2013
$1.6M

Tags

Signum Biosciences

Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation (STM) platform to modulate signal transduction imbalances. Through research on protein networks that control biological systems, Signum is developing therapeutic agents for several skin conditions, Alzheimer’s, Parkinson’s, asthma and COPD. Signum’s STM technology provides many opportunities for the development of novel consumer products and pharmaceutical candidates.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. Signum Dermalogix receives $1.6m Phase II SBIR grant to develop atopic dermatitis therapeutics (itsoftware.pharmaceutical-business-review.com) [edit]
Edit This Page
Last Edited 11/15/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy